News

Breakthrough promises ultra-high-resolution spectroscopy with wide variety of applications By Jed Thomas A new study ...
At OFC 2025, imec unveiled a proof of concept for a photonics-based CDM FMCW 144-GHz distributed radar system, which could ...
When an ordinary beam of neutrons strikes the team’s silicon grating, the millions of scored lines on the grating convert the ...
Onctura commences randomized Phase I/II study in non-small cell lung cancer First patient dosed in study investigating roginolisib + dostarlimab +/- docetaxel in patients with NSCLC who have ...
However, controlling beam trajectories in the THz band has been challenging due to the complexity and high costs associated with traditional phase or amplitude modulation techniques, which often ...
Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed.
The reader can detect variations in the phase of the reflection coefficient due to the motion of the encoder. To validate the encoder system, two encoders are implemented in a low-loss rigid substrate ...
Updated results from the Phase III ELATIVE trial reveal Iqirvo (elafibranor) significantly reduced fatigue in patients with ...
BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...
Q1 2025 Earnings Conference Call May 9, 2025 4:30 PM ET. Company Participants. Bernie Hertel - Head of Investor Relations Punit Dhillon - Presi ...